Chicago—New research findings in the field of personalized medicine could help oncologists understand the characteristics that determine why patients respond differently to therapeutic drugs. The studies were presented recently at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).
“This exciting field gives cancer doctors new tools to identify the most appropriate treatment for each patient while avoiding overtreatment with drugs that have potentially toxic side effects,” said Julie Gralow, MD, chair of ASCO's cancer communications committee and associate professor of medicine at the University of Washington in Seattle.
Hampton T. Studies Explore Factors That Underlie Varied Responses to Cancer Drugs. JAMA. 2008;300(2):155-156. doi:10.1001/jama.300.2.155